Effect of combination therapy with ribavirin and human interferon alfa on subacute sclerosing panencephalitis (SSPE) virus in hamsters

1996 ◽  
Vol 30 (1) ◽  
pp. A55
Keyword(s):  
Combination Therapy ◽  
Subacute Sclerosing Panencephalitis ◽  
Interferon Alfa ◽  
Human Interferon ◽  
Sspe Virus

Use of Protein a Conjugated to Peroxidase to Localize Immunoglobulin G in SSPE Ferret Brain

1982 ◽  
Vol 40 ◽  
pp. 350-351
Author(s):  
Hannah R. Brown ◽  
Anthony F. Nostro ◽  
Halldor Thormar
Keyword(s):  
Immunoglobulin G ◽  
Human Disease ◽  
Measles Virus ◽  
Subacute Sclerosing Panencephalitis ◽  
Protein A ◽  
Inflammatory Lesions ◽  
Sspe Virus ◽  
Specific Immunoglobulin ◽  
Antibody Titers ◽  
The Brain

Subacute sclerosing panencephalitis (SSPE) is a slowly progressing disease of the CNS in children which is caused by measles virus. Ferrets immunized with measles virus prior to inoculation with the cell associated, syncytiogenic D.R. strain of SSPE virus exhibit characteristics very similar to the human disease. Measles virus nucleocapsids are present, high measles antibody titers are found in the sera and inflammatory lesions are prominent in the brains. Measles virus specific immunoglobulin G (IgG) is present in the brain,and IgG/ albumin ratios indicate that the antibodies are synthesized within the CNS.

scholarly journals Response to Combination Therapy with Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C According to a TNF-α Promoter Polymorphism

Digestion ◽  
2003 ◽  
Vol 68 (1) ◽  
pp. 1-4 ◽  
Author(s):  
U. Schiemann ◽  
J. Glas ◽  
P. Török ◽  
C. Simperl ◽  
K. Martin ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Combination Therapy ◽  
Chronic Hepatitis C ◽  
Promoter Polymorphism ◽  
Interferon Alfa ◽  
Tnf Α

scholarly journals The Combination Therapy with Peg-interferon Alfa and Ribavirin for Chronic Hepatitis C in Korea as an Initial Treatment

2012 ◽  
Vol 27 (2) ◽  
pp. 111
Author(s):  
Dong Hyun Park ◽  
Sang Uk Lee ◽  
Jin Seok Yu ◽  
Jun Seop Lee ◽  
Hye Jung Kwon
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Combination Therapy ◽  
Chronic Hepatitis C ◽  
Initial Treatment ◽  
Interferon Alfa

Safety, tolerability and efficacy of interferon alfa 2b and Ribavirin combination therapy in HCV patients with cirrhosis

2003 ◽  
Vol 124 (4) ◽  
pp. A383
Author(s):  
Ravi Ravinuthala ◽  
Vosudesh Pai ◽  
Dilip Moonka ◽  
Kimberly Brown
Keyword(s):  
Combination Therapy ◽  
Interferon Alfa

Multicenter study on the treatment of chronic NANB hepatitis with recombinant human interferon alfa-2b

1990 ◽  
Vol 11 ◽  
pp. S163
Author(s):  
M Piazza ◽  
V Guadagnino ◽  
L Picciotto ◽  
G Borgia ◽  
R Orlando ◽  
...  
Keyword(s):  
Multicenter Study ◽  
Interferon Alfa ◽  
Human Interferon ◽  
Nanb Hepatitis ◽  
Chronic Nanb ◽  
Chronic Nanb Hepatitis

Treatment of relapsing-remittent multiple sclerosis with recombinant human interferon-alfa-2a: design of a randomised, placebo-controlled, double blind trial in Norway

1996 ◽  
Vol 1 (6) ◽  
pp. 372-375 ◽  
Author(s):  
H Nyland ◽  
K-M Myhr ◽  
F Lillås ◽  
AI Smievoll ◽  
T Riise ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Primary Objective ◽  
Interferon Alfa ◽  
Controlled Study ◽  
Human Interferon ◽  
New Disease ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Drug Free

A multicentre, randomised, double-blind, placebo controlled study to evaluate the efficacy and safety of 4.5 and 9.0 MIU recombinant human interferon alfa-2a (Rof eron-A™) given thrice weekly in patients with relapsing-remittent multiple sclerosis is described. The patients are treated for 6 months followed by a 6 months drug-free period. The primary objective is to determine new disease activity analysed by monthly MRI with gadodiamide (GdDTPA-BMA, Omniscan™). The study is conducted at eight centers in Norway and is completed in January 1996.

Multiple sclerosis and human interferon alfa

JAMA ◽  
1989 ◽  
Vol 262 (19) ◽  
pp. 2684b-2684
Author(s):  
J. T. Coyle
Keyword(s):  
Multiple Sclerosis ◽  
Interferon Alfa ◽  
Human Interferon
Sign in / Sign up

Export Citation Format

Share Document